Showing 5171-5180 of 5909 results for "".
- NIH Mobilizes National Innovation Initiative For COVID-19 Diagnosticshttps://modernod.com/news/nih-mobilizes-national-innovation-initiative-for-covid-19-diagnostics/2477698/The National Institutes of Health (NIH) announced a new initiative aimed at speeding innovation, development, and commercialization of COVID-19 testing technologies. With a $1.5 billion investment from federal stimulus funding, the newly launched Rapid Acceleration of Diagnostics (RADx) in
- Roche Wins US Nod For COVID-19 Antibody Test, Aims to Boost Outputhttps://modernod.com/news/roche-wins-us-nod-for-covid-19-antibody-test-aims-to-boost-output/2477694/Roche has won emergency approval from the FDA for an antibody test to determine whether people have ever been infected with the coronavirus, the Swiss drugmaker said on Sunday, according to a Reuters
- CheckedUp Launches Virtual Visits Telehealth Platform for Specialty Carehttps://modernod.com/news/checkedup-launches-virtual-visits-telehealth-platform-for-specialty-care/2477689/CheckedUp announced the launch of CheckedUp Virtual Visits, a telemedicine system designed to improve virtual specialty care. CheckedUp Virtual Visits was created to keep patients and physicians at the center of pivotal health care decisions as “point of care” engagement evolves with pa
- Diabetic Retinopathy Approaches Refined by New Trial Resultshttps://modernod.com/news/diabetic-retinopathy-approaches-refined-by-new-trial-results/2477686/Data from clinical trials are prompting leading diabetic retinopathy specialists to change their approach to treatment, according to a Medscape report. The Protocol studies conducted by the DRCR Retina Network, which is funded by t
- An Imaging Method To Help Us See Behind Our Eyeshttps://modernod.com/news/an-imaging-method-to-help-us-see-behind-our-eyes/2477684/The choroidal and retrobulbar blood vessels sit at the deep region of our eyes, supplying oxygen and nutrients to the retina. They are vital to our vision and the health and structure of our eyes. However, we don’t understand these important blood vessels as well as we should, because current ima
- Gilead Says Early Results of Coronavirus Drug Trial Show Improvement With Shorter Remdesivir Treatmenthttps://modernod.com/news/gilead-says-early-results-of-coronavirus-drug-trial-show-improvement-with-shorter-remdesivir-treatment/2477673/Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks, according to a CNBC
- AAPS: Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patientshttps://modernod.com/news/aaps-hydroxychloroquine-has-about-90-percent-chance-of-helping-covid-19-patients/2477670/In a letter to Gov. Doug Ducey of Arizona, the Association of American Physicians and Surgeons (AAPS) presented a
- Widely Used Surgical Masks Are Putting Health Care Workers At Serious Riskhttps://modernod.com/news/widely-used-surgical-masks-are-putting-health-care-workers-at-serious-risk/2477666/With medical supplies in high demand, federal authorities say health workers can wear surgical masks for protection while treating COVID-19 patients—but growing evidence suggests the practice is putting workers in jeopardy, according to a
- Congress Urges FDA to Better Police, Evaluate COVID-19 Antibody Testshttps://modernod.com/news/congress-urges-fda-to-better-police-evaluate-covid-19-antibody-tests/2477665/Members of Congress have called on the FDA to re-evaluate its stance toward COVID-19 antibody tests. Since mid-March, the agency has allowed diagnostic developers to bring their products to market without any outside evaluation that the results they produce are accurate, according to a
- Clearside Biomedical Revises NDA Resubmission Timeline and Xipere Commercial Partnership with Bausch Healthhttps://modernod.com/news/clearside-biomedical-revises-nda-resubmission-timeline-and-xipere-commercial-partnership-with-bausch-health/2477660/Clearside Biomedical announced an update to the Xipere (triamcinolone acetonide suprachoroidal injectable suspension) new drug application (NDA) resubmission timeline and to its commercialization and development partnership with Bausch Health Companies and Bausch + Lomb.